AudioCure Pharma
Latest round
- Series A
Last raised
- Jul 2016
Total raised
- $10M
Investors
- 2
About AudioCure Pharma
Founded in 2012 in Berlin, Germany, AudioCure Pharma GmbH is engaged in the research and development of drug therapies aimed at repairing hearing impairments.265 mn.AudioCure Pharma GmbH specializes in the development of innovative drug treatments for hearing disorders, focusing on conditions such as sensorineural hearing loss and tinnitus, which currently lack approved pharmacological therapies. The company's lead product candidate, AC102, is a novel molecule designed to protect and restore the cellular components essential for hearing within the inner ear. This therapeutic approach addresses the root causes of these disorders rather than merely alleviating symptoms, potentially marking a significant advancement in the treatment of acute hearing loss and acute tinnitus. AudioCure targets a broad client base, including healthcare providers, hospitals, and research institutions, primarily within Europe and North America, where there is a high prevalence of hearing disorders among the population.3. The company operates within a pharmaceutical framework that involves B2B transactions, generating revenue primarily from partnerships with pharmaceutical distributors and healthcare providers, as well as direct sales of their flagship product AC102 to hospitals and clinics. The company aims to expand its reach into new markets within Europe and North America by enhancing its product offerings and increasing engagement with healthcare providers.
Who invested in AudioCure Pharma
2 investors across 2 rounds
See all investors in AudioCure Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AudioCure Pharma
Who invested in AudioCure Pharma?
AudioCure Pharma has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AudioCure Pharma raised?
AudioCure Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AudioCure Pharma last raise money?
AudioCure Pharma's most recent round on record is a Series A, in Jul 2016.
What does AudioCure Pharma do?
Founded in 2012 in Berlin, Germany, AudioCure Pharma GmbH is engaged in the research and development of drug therapies aimed at repairing hearing impairments.
Where is AudioCure Pharma headquartered?
AudioCure Pharma is headquartered in Berlin, Germany.
Which VCs invest in companies like AudioCure Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at AudioCure Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like AudioCure Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.